Unknown

Dataset Information

Trends in redo mitral procedure for treating mitral bioprostheses failure: a single center's experience.


ABSTRACT:

Background

Transcatheter mitral valve-in-valve implantation (TM-VIV) has emerged as a viable and attractive alternative to surgical mitral valve replacement (SMVR). This study aimed to review a single-center experience with redo mitral procedure for mitral bioprostheses failure over an 8-year period. In addition, it compared procedural safety and early outcomes of various approaches.

Methods

Between January 2013 and January 2021, 79 consecutive patients who underwent redo procedure for mitral bioprostheses failure in our institution were retrospectively reviewed. SMVR and transapical TM-VIV were performed in 54 and 25 patients, respectively. In the SMVR group, 12 patients underwent totally thoracoscopic redo mitral valve replacement (MVR).

Results

The annual volume of

SUBMITTER: Liu J 

PROVIDER: S-EPMC8422140 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature